Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • PwC certifies KELES as first VC-firm to achieve SFDR Article 9 for digital health investment

    Mar 25, 2025, 08:02 AM by
    Full story
  • DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis

    Mar 25, 2025, 08:02 AM by
    DNAnexus announces collaboration with AlidaBio to advance epitranscriptomics research and discovery.
    Full story
  • Novartis Strengthens Cardiovascular Portfolio with $3.08 Billion Anthos Therapeutics Acquisition

    Mar 24, 2025, 08:17 AM by
    Anthos Therapeutics, Inc., a business that produces abelacimab (full human monoclonal antibody), a late-stage medication being developed to prevent stroke and systemic embolism in patients with atrial fibrillation, has agreed to be acquired by Novartis. Upon concluding the deal, Novartis will pay $925 million upfront, subject to certain usual adjustments. If certain sales and regulatory milestones are met, Novartis may also pay an additional $2.15 billion.
    Full story
  • Femasys Secures European Approval for FemBloc Delivery System, Paving the Way for the First Non-Surgical Permanent Birth Control

    Mar 21, 2025, 08:30 AM by
    European women will soon be able to receive permanent birth control through a non-surgical approach. FemBloc, developed by Femasys, a leading biomedical innovator addressing significant unmet needs in women's health worldwide, announces Conformité Européene (CE) mark certification under the European Union Medical Device Regulation (EU MDR) as the first regulatory approval in the world for the FemBloc® delivery system for non-surgical female permanent birth control.
    Full story
  • Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs

    Mar 21, 2025, 08:30 AM by
    Coronado Research has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and operational implementation experience across the industry and product lifecycle.
    Full story
  • CariGenetics launches Caribbean Genome Programme with Oxford Nanopore to drive regional genomic research

    Mar 20, 2025, 08:28 AM by
    CariGenetics and Oxford Nanopore Technologies have launched the Caribbean Genome Programme, the first large-scale genomic sequencing initiative in the region. This pioneering effort is set to address unmet need in advancing regional genetic research in the Caribbean, providing real-time, high throughput sequencing to address critical health disparities, starting with men’s health.
    Full story
  • InSysBio announces its collaboration with discoveric bio alpha

    Mar 20, 2025, 08:28 AM by
    The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid.
    Full story
  • Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

    Mar 20, 2025, 08:28 AM by
    Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking pathologist workforce.
    Full story
  • InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities

    Mar 20, 2025, 08:28 AM by
    InformedDNA has acquired Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. The combination significantly expands patient, provider and payor access to a broader range of genetic insights and enables more personalized, data-driven treatment and medication decisions for better outcomes and reduced healthcare costs.
    Full story
  • Elsevier Launches AI Search, Summary, Comparison Tool for ScienceDirect

    Mar 20, 2025, 01:00 AM by User Not Found
    Bio-IT World| Last week, Elsevier launched ScienceDirect AI, a generative AI tool for researchers that will extract, summarize and compare trusted insights from millions of full-text articles and book chapters on ScienceDirect.
    Full story
  • START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

    Mar 19, 2025, 08:33 AM by
    START's site network solidifies its global leadership in urological cancer trials.
    Full story
  • Clearwater Joins CancerX to Help Drive Strong Cybersecurity and Data Privacy Practices in the Fight Against Cancer

    Mar 19, 2025, 08:33 AM by
    Full story
  • Sirio Launches Global Research Institute for Longevity Studies [SIA]

    Mar 19, 2025, 08:33 AM by
    Full story
  • Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

    Mar 19, 2025, 08:33 AM by
    Sapio Sciences today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery.
    Full story
  • Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH

    Mar 19, 2025, 08:33 AM by
    This press release highlights the recent ruling by the United States District Court for the Central District of California, which denied QIAGEN’s Partial Motion to Dismiss and, in the alternative, to stay counterclaims brought by Zymo Research, including claims of patent unenforceability and antitrust violations.
    Full story
  • Bio-IT World Names Innovative Practices Winners

    Mar 19, 2025, 01:01 AM by User Not Found
    Bio-IT World| Bio-IT World has named the 2025 Innovative Practices Awards winners, choosing to honor four entries. Winners this year include Genmab nominated by Genedata, NHS England nominated by IQVIA, Pistoia Alliance, and Regeneron. The judging panel also highlighted two entries for Honorable Mention: a separate entry from Pistoia Alliance and Quris-AI.
    Full story
  • Coronado Research Announce the Appointment of Stephen Ralston as EVP Market Access and HEOR

    Mar 18, 2025, 08:27 AM by
    Coronado Research, a consultancy-led, professional services organisation providing support to pharmaceutical, biotechnology, and medical device companies, has appointed Stephen Ralston as EVP Market Access and Health Economics Outcomes Research (HEOR).
    Full story
  • Flatiron Health Enables Patient-Level Data Sharing Across National Borders

    Mar 18, 2025, 01:00 AM by User Not Found
    Bio-IT World| Patient-level real-world data (RWD) derived from harmonized electronic health records (EHRs) across four countries will help power multinational oncology research of the future, thanks to groundbreaking, collaborative efforts of Flatiron Health scientists working in the U.S., UK, Germany, and Japan.
    Full story
  • Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit

    Mar 14, 2025, 08:09 AM by
    The press release highlights the Quick-16S™ Full-Length Library Prep Kit, which offers the fastest, most streamlined full-length 16S library preparation workflow. With as little as 30 minutes of hands-on time, the kit prepares 96 samples while ensuring high-quality libraries. The kit is optimized for both PacBio® SMRTbell® and Kinnex™ library prep kits, and is fully compatible with ONT® platforms, making it a versatile solution for diverse sequencing applications. Additionally, the integrated qPCR dye provides real-time quality control to guarantee the highest standards for every library.
    Full story
  • Coronado Research Announce the Appointment of Nick Littlebury as EVP, Regulatory Affairs

    Mar 14, 2025, 08:09 AM by
    Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle.
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy